CROTTI, CHIARA
CROTTI, CHIARA
Universita' degli Studi di MILANO
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study
2023 C. Crotti, R. Di Taranto, F. Orsini, M. Ferrito, M. Varenna, E.G. Favalli, R. Caporali
Long-term use of burosumab for the treatment of tumor-induced osteomalacia
2023 C. Crotti, F. Zucchi, C. Alfieri, R. Caporali, M. Varenna
A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis
2022 M. Varenna, C. Crotti, M.T. Bonati, F. Zucchi, M. Gallazzi, R. Caporali
Tumor induced osteomalacia: A single center experience on 17 patients
2021 C. Crotti, F. Bartoli, L.A. Coletto, M. Manara, E. Marini, P.A. Daolio, A. Parafioriti, E. Armiraglio, F. Zucchi, L. Sinigaglia, R. Caporali, M. Varenna
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis
2021 N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino
Decreasing severity of Paget's disease of bone in northern Italy over the last two decades: results of a monocentric study on 391 patients
2021 M. Varenna, F. Zucchi, C. Crotti, M. Manara, R. Caporali
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects
2019 C. Crotti, E. Agape, A. Becciolini, M. Biggioggero, E.G. Favalli
Upadacitinib and filgotinib: The role of JAK1 selective inhibition in the treatment of rheumatoid arthritis
2019 M. Biggioggero, A. Becciolini, C. Crotti, E. Agape, E.G. Favalli
Tocilizumab in the treatment of rheumatoid arthritis : An evidence-based review and patient selection
2019 M. Biggioggero, C. Crotti, A. Becciolini, E.G. Favalli
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis
2019 C. Crotti, M. Biggioggero, A. Becciolini, E. Agape, E.G. Favalli
Sex and Management of Rheumatoid Arthritis
2019 E.G. Favalli, M. Biggioggero, C. Crotti, A. Becciolini, M.G. Raimondo, P.L. Meroni
The management of acute anterior uveitis complicating spondyloarthritis: Present and future
2018 M. Biggioggero, C. Crotti, A. Becciolini, E. Miserocchi, E.G. Favalli
Vitamin D and spondyloarthritis: Review of the literature
2018 C. Crotti, A. Becciolini, M. Biggioggero, E.G. Favalli
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy
2018 C. Crotti, N.B. Watts, M. De Santis, A. Ceribelli, G. Fabbriciani, F. Cavaciocchi, B. Marasini, C. Selmi, M. Massarotti
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept : Retrospective analysis of a local registry
2018 E.G. Favalli, A. Becciolini, M. Biggioggero, I. Bertoldi, C. Crotti, M.G. Raimondo, A. Marchesoni
Sarilumab : patient-reported outcomes in rheumatoid arthritis
2018 C. Crotti, M. Biggioggero, A. Becciolini, E.G. Favalli
Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon : a systematic review and meta-analysis
2017 F. Ingegnoli, N. Ughi, C. Crotti, M. Mosca, C. Tani
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date
2017 C. Crotti, M.G. Raimondo, A. Becciolini, M. Biggioggero, E.G. Favalli
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability
2017 A. Becciolini, M.G. Raimondo, C. Crotti, E. Agape, M. Biggioggero, E.G. Favalli
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences
2017 E.G. Favalli, I. Pontikaki, A. Becciolini, M. Biggioggero, N. Ughi, M. Romano, C. Crotti, M. Gattinara, V. Gerloni, A. Marchesoni, P.L. Meroni